Search for other papers by Jan Roar Mellembakken in
Google Scholar
PubMed
Search for other papers by Azita Mahmoudan in
Google Scholar
PubMed
Search for other papers by Lars Mørkrid in
Google Scholar
PubMed
Search for other papers by Inger Sundström-Poromaa in
Google Scholar
PubMed
Search for other papers by Laure Morin-Papunen in
Google Scholar
PubMed
Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Uusimaa, Finland
Search for other papers by Juha S Tapanainen in
Google Scholar
PubMed
Search for other papers by Terhi T Piltonen in
Google Scholar
PubMed
Search for other papers by Angelica Lindén Hirschberg in
Google Scholar
PubMed
Search for other papers by Elisabet Stener-Victorin in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, St. Olav’s Hospital, Trondheim, Norway
Search for other papers by Eszter Vanky in
Google Scholar
PubMed
Search for other papers by Pernille Ravn in
Google Scholar
PubMed
Search for other papers by Richard Christian Jensen in
Google Scholar
PubMed
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
risk of the metabolic syndrome, which could be associated with increased risk of cardiovascular disease (CVD) ( 3 ). The definition of the metabolic syndrome includes elevated blood pressure (BP) ( 3 ). It is estimated that more than 30% of women with
Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Christian Høst in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Search for other papers by Mogens Erlandsen in
Google Scholar
PubMed
Search for other papers by Kristian A Groth in
Google Scholar
PubMed
Search for other papers by Kurt Kristensen in
Google Scholar
PubMed
Search for other papers by Anne Grethe Jurik in
Google Scholar
PubMed
Search for other papers by Niels H Birkebæk in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
hypergonadotropic hypogonadism ( 3 ). The incidence of the metabolic syndrome and insulin resistance is considerably higher in patients with KS ( 4 , 5 ), and epidemiological studies show an increased mortality due to diabetes as well as diseases of the
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Hairong Hao in
Google Scholar
PubMed
Search for other papers by Linghui Kong in
Google Scholar
PubMed
Search for other papers by Jie Zhang in
Google Scholar
PubMed
Search for other papers by Feng Bai in
Google Scholar
PubMed
Search for other papers by Fei Guo in
Google Scholar
PubMed
Search for other papers by Pan Wei in
Google Scholar
PubMed
Search for other papers by Rui Chen in
Google Scholar
PubMed
Search for other papers by Wen Hu in
Google Scholar
PubMed
membrane lipids, which also play an important role in the aetiology of metabolic syndrome as cellular signalling molecules. The fact that the accumulation of fat in tissues, such as muscle and liver, is associated with insulin resistance throughout the
Search for other papers by Chenyu Jiang in
Google Scholar
PubMed
Search for other papers by Mi Zhou in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Meng Chen in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Kaifeng Hu in
Google Scholar
PubMed
Search for other papers by Yujie Wu in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Yangyu Zhao in
Google Scholar
PubMed
Search for other papers by Xinghui Liu in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
the mother and the infant, such as preeclampsia, higher cesarean rate, macrosomia, neonatal hypoglycemia, and long-term effects, including a higher risk of type 2 diabetes, cardiovascular events of mothers, and overweight and metabolic syndrome of
Search for other papers by Huguette S Brink in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Joke van der Linden in
Google Scholar
PubMed
). Increased visfatin levels have been reported in obesity, metabolic syndrome and T2DM ( 59 , 60 ). In pregnancy, visfatin levels progressively increase up to the second trimester, after which they decrease again with the lowest concentrations observed in the
Search for other papers by Jun-Xin Yan in
Google Scholar
PubMed
Search for other papers by Bin-Jing Pan in
Google Scholar
PubMed
Search for other papers by Ping-Ping Zhao in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Li-Ting Wang in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Jing-Fang Liu in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Song-Bo Fu in
Google Scholar
PubMed
metabolic syndrome (MS), or metabolic dysfunction-associated fatty liver disease. NAFLD is one of the most common chronic liver diseases in the world. The report estimated the prevalence of NAFLD is 25% globally, 23% in Europe, the highest in the Middle East
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Search for other papers by Reshma Aziz Merchant in
Google Scholar
PubMed
Search for other papers by Michael Wong Wai Kit in
Google Scholar
PubMed
Search for other papers by Jia Yi Lim in
Google Scholar
PubMed
Search for other papers by John E Morley in
Google Scholar
PubMed
most recent study, abdominal obesity measured by increased waist-hip ratio and not metabolic syndrome was associated with increased respiratory deterioration in COVID-19 ( 28 , 29 ). WC and abdominal obesity are also associated with vertebral fracture
Department of Science and Environment, Roskilde University, Roskilde, Denmark
Search for other papers by Pernille Bækgaard Udesen in
Google Scholar
PubMed
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Anja Elaine Sørensen in
Google Scholar
PubMed
Search for other papers by Rikke Svendsen in
Google Scholar
PubMed
Department of Clinical Immunology, Næstved Hospital, Næstved, Denmark
Search for other papers by Nanna Louise Skov Nielsen in
Google Scholar
PubMed
Search for other papers by Marie Louise Muff Wissing in
Google Scholar
PubMed
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Search for other papers by Anne Lis Mikkelsen Englund in
Google Scholar
PubMed
Search for other papers by Louise Torp Dalgaard in
Google Scholar
PubMed
designed to include a total of 21 miRNAs ( 40 , 49 , 62 ) and miRNAs reported in the literature to be associated with metabolic syndrome, insulin resistance or diabetes (Supplementary Table 1, see section on supplementary materials given at the end of
Search for other papers by Vittorio Unfer in
Google Scholar
PubMed
Search for other papers by Fabio Facchinetti in
Google Scholar
PubMed
Search for other papers by Beatrice Orrù in
Google Scholar
PubMed
Search for other papers by Barbara Giordani in
Google Scholar
PubMed
Search for other papers by John Nestler in
Google Scholar
PubMed
prevent and/or treat a number of metabolic disorders related to IR, such as the metabolic syndrome ( 4 , 5 ), gestational diabetes mellitus ( 6 , 7 , 8 , 9 , 10 ) and the polycystic ovary syndrome (PCOS) ( 11 , 12 , 13 ). PCOS is a heterogeneous
epiWELL, LLC, Ithaca, New York, USA
Search for other papers by Magnolia Ariza-Nieto in
Google Scholar
PubMed
Search for other papers by Joshua B Alley in
Google Scholar
PubMed
Search for other papers by Sanjay Samy in
Google Scholar
PubMed
Search for other papers by Laura Fitzgerald in
Google Scholar
PubMed
Search for other papers by Francoise Vermeylen in
Google Scholar
PubMed
Search for other papers by Michael L Shuler in
Google Scholar
PubMed
Search for other papers by José O Alemán in
Google Scholar
PubMed
(pre-RYGB) was used as control for the changes that occurred 12 weeks post RYGB. Metabolic syndrome – as defined by International Diabetes Federation (IDF) criteria ( 21 ). Blood collection and biochemical analysis Fasting non-heparinized blood